Yasmin

   
Google
 
Web NewDrugInformation.com

Yasmin


Drug - Yasmin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Drospirenone; Ethinyl Estradiol
Multiple ingredients are in alphabetical order.

Strength - 3MG;0.03MG
The potency of the active ingredient(s), Drospirenone; Ethinyl Estradiol. May repeat for multiple part products.

Applicant - BERLEX
The firm name holding legal responsibility for Yasmin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021098
The FDA assigned number to Yasmin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Yasmin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 11, 2001
The date Yasmin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Yasmin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Yasmin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Berlex Inc
The full name of the firm holding legal responsibility for the new application of Yasmin.

Yasmin